After India has made a mark in marketing the first experimental preventive Covid-19 drug, it is on its way to develop its own indigenous vaccine. After the Central Drugs Standard Control Organisation has allowed Bharat Boitech India (BBIL) to start human trials, Covaxin might become the first Indian vaccine candidate to prevent the spread of ...

India’s coronavirus contracted cases seem to have overtaken even Italy with a single day spike being reported to more than 7000 cases. Reports of casing shooting up are coming from everywhere in India. Cases are reported more from Maharashtra and Orissa. Currently, a nationwide tally of confirmed Covid-19 cases has, unfortunately, crossed a 1.6 lakh ...

Reduction Of Infectious Cases: The efficacy of the Covid-19 vaccine could be affected if the Covid-19 virus infections come down, confirms official reports. The researchers are stating that it would be difficult for them to test the vaccine in its third phase. This is primarily for the other vaccine candidates being developed and could delay ...

Domestic Coronavirus Vaccine: Keeping his promise of making India self-reliant, PM Narendra Modi expressed his joy in announcing two homemade Corona virus vaccines would be made available to public soon.  Speaking on the virtual inauguration of the 16th Pravasi Bharatiya Divas convention, Modi addressed the nation and expressed his joy over things that happened in ...

India In Talks With Moderna: The US biotech giant Moderna Therapeutics has confirmed that its Covid-19 vaccine sample guarantees a 94.5% success rate in its phase 3 efficacy trials. The Indian government is apparently in talks with the company over the development of the company’s vaccine candidate.  According to a senior government official, “India is ...

The union health ministry launched a website that will provide continually updated information on the status of vaccine development and trials in India. Union Health Minister Harsh Vardhan announced the launch of the ‘vaccine web portal’ and the ‘national clinical registry for COVID-19’, developed for the Indian Council of Medical Research (ICMR). The portal will ...

The Serum Institute of India which had paused the trials of Oxford-AstraZeneca vaccine has been allowed to restart them. The Drugs Controller General of India (DCGI) has allowed the Serum Institute of India (SII) to continue testing the Oxford-AstraZeneca vaccine after it had been suspended on September 11, following an unexplained neurological illness in one ...